EPIRUS Biopharmaceuticals, Inc. Proceeds from Long-Term Debt Issued
EPIRUS Biopharmaceuticals, Inc. reported Proceeds from Long-Term Debt Issued of $7.29 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2015-03-31
- EPIRUS Biopharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2011-12-31 was $8.49M.
- EPIRUS Biopharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2011-09-30 was $0.00.
- EPIRUS Biopharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2014 was $7.29M.
- EPIRUS Biopharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- EPIRUS Biopharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2011 was $16.98M, a 492.02% increase from fiscal 2010.
- EPIRUS Biopharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2010 was $2.87M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2014-12-31 | $7.29M 10-K · filed 2015-03-31 | |||
| 2012-12-31 | $0.00 10-K · filed 2013-03-07 | |||
| 2011-12-31 | $8.49M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $8.49M derived: sum of 2 quarters · filed 2014-03-14 | $16.98M 10-K · filed 2014-03-14 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $8.49M 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $8.49M 10-Q · filed 2012-08-07 | |||
| 2010-12-31 | $2.87M 10-K · filed 2013-03-07 |